Guaifenesin 68001-0561-17
- Manufacturer
- Bluepoint Laboratories
- Dosage Form
- Tablet, Extended Release
- Route
- Oral
- Product Type
- Human Otc Drug
- Marketing Start
- March 15, 2023
- Listing Expires
- December 31, 2026
- Application
- ANDA210453
Active Ingredients
| Ingredient | Strength |
|---|---|
| Guaifenesin | 600 mg/1 |
Drug Class
Expectorant [EPC]Decreased Respiratory Secretion Viscosity [PE]Expectorant [EPC]
Selected Package
68001-0561-17Selected8 BLISTER PACK in 1 CARTON (68001-561-17) / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (68001-561-16)